title: Vaccination versus "wait and treat": how to subsidize them?
abstract: In this paper we discuss the application of different co-payment rates to alternative medical strategies. Two such strategies are considered: a "vaccination strategy", in which patients apply preventive measures before knowing if they have the disease, and a "wait and treat" strategy, in which patients are treated later only if they contract the disease. We show the second approach should be more generously subsidized by the regulator. This is, at least at first sight, a surprising result.
authors.affiliation: Catholic Faculties of Mons, 151, Chaussee de Binche, 7000, Mons, Belgium. louis.eeckhoudt@fucam.ac.be
authors.forename: Louis
authors.initials: L
authors.lastname: Eeckhoudt
authors.forename: Maurice
authors.initials: M
authors.lastname: Marchand
authors.forename: Pierre
authors.initials: P
authors.lastname: Pestieau
authors.forename: Gwenaël
authors.initials: G
authors.lastname: Piaser
mesh_terms: D017047:Cost Sharing; D003657:Decision Making; D005060:Europe; D005380:Financing, Government / Q000191:economics*; D006801:Humans; D017059:Models, Econometric; D014611:Vaccination / Q000191:economics / Q000706:statistics & numerical data